Topps Tiles CEO leaves, replaced by CFO
MC Mining shares dip despite Generaal Mining Right approval
The Generaal Project contains more than 407 million gross tonnes of inferred coal resources, which supports the MC Mining strategy of being South Africa’s pre-eminent producer of hard coking coal.
The Group submitted its mining right applications for the three GSP projects to the South African Department of Mineral Resources in 2013. The Generaal Project mining right is the second of the applications to be granted, following the Chapudi Project being granted in December 2018. Elsewhere, KEFI Minerals PLC (LON: KEFI) said it was still waiting for a go-ahead at the Tulu Kapi Gold project and Panther Metals Plc (NEX: PALM) secured a lucrative exploration licence. Meanwhile, Shanta Gold Limited (LON: SHG) and Mining company Capital Mining Ltd (LON: CAPD) both reported impressive third quarters.MC Mining comments
David Brown, Chief Executive Officer, stated,
“The granting of the Generaal Project mining right is a further step in unlocking value from MC Mining’s significant coking and thermal coal assets, positioning the GSP to be a potential long-term coal supplier to industrial users both local and offshore, including the planned Musina-Makhado SEZ.”
“The long-term development of the three GSP project areas is complementary to our flagship Makhado hard coking coal project, also in the Soutpansberg Coalfield. The Company has made significant progress in advancing Makhado during the last 12 months and anticipates completing the Phase 1 capital raise process in the near-term in order to facilitate the commencement of construction in Q1 CY2020. The conclusion of domestic and export Makhado Phase 1 and Phase 2 off-take agreements reflects the market appetite for hard coking coal and the significant potential of projects located in this coalfield.”
Investor notes
The Company’s shares dipped by 6.67% or 2.00p to 28.00p 05/11/19 13:25 GMT. Analysts from Peel Hunt reiterated their ‘Buy’ stance on MC Mining stock. Neither a p/e ratio nor dividend yield are available, the Group’s market cap is £42.26 million.Suzuki report quarterly slip amid Indian market slump
AIB shares fall despite positive update
Kenmare Resources names new Non-Executive Director
In conjunction with her appointment to the Board, Dr. Dorward-King will also become a member of Kenmare Resources’s Sustainability Committee.
Elsewhere in mining, KEFI Minerals PLC (LON: KEFI) said it was still waiting for a go-ahead at the Tulu Kapi Gold project, while Panther Metals Plc (NEX: PALM) secured a lucrative exploration licence and Shanta Gold Limited (LON: SHG) reported an impressive third quarter.
Kenmare Resources comments
Steven McTiernan, Chairman, stated,“I am delighted to welcome Elaine to Kenmare’s Board. Her significant leadership experience in both mineral sands and sustainability will complement the existing skillset of our Directors to ensure a strong balance of skills, experience and diversity.
Kenmare is focused on operating responsibly, with a progressive land rehabilitation programme, the majority of our power needs supplied by hydropower and no chemicals used in our mining or processing operations. We look forward to Elaine’s counsel as we strive to continually improve our environmental, social and governance performance.”
Investor notes
Following the update, the Company’s shares have dipped 0.41% or 1.00p to 244.00p per share. Analysts from Peel Hunt reiterated their ‘Buy’ stance on Kenmare Resources stock. The Group’s p/e ratio is 6.86 and their dividend yield stands at 0.85%.
Gem Diamonds shares jump despite reduced sales outlook
Verona Pharma widen third quarter loss
Additionally, more established names such as Pfizer (NYSE: PFE) have smashed their third quarter, expanding their market dominance.
For the nine months to September 30, pretax loss widened to £33.7 million from £18.3 million after a more than doubling of R&D costs to £27.8 million from £13.6 million.
A 28% increase in general & administrative costs to £5.9 million from £4.6 million also saw the loss widen for Verona.
Chief Executive Jan-Anders Karlsson said: “We are very pleased that our four-week phase 2b dose-ranging clinical trial with nebulized ensifentrine is progressing according to plan and that we have completed enrollment of over 400 symptomatic patients with moderate to severe COPD. We anticipate completing this study around the end of 2019. Informed by this and prior studies in around 850 subjects, we plan to advance into our phase 3 clinical trial program which we expect to commence in 2020 following an end of phase 2 meeting with the [US Food & Drug Administration].
“Karlsson added: “Initially we will focus on nebulized treatment for more severe patients but we are very excited by the positive [dry powder inhaler] formulation results that support our view that ensifentrine is an effective bronchodilator in COPD patients, whether administered as a dry powder via a handheld inhaler or as a suspension via a nebulizer.”
As a result, shares of Verona sunk 3.08% to trade at 44p per share. 5/11/19 BST.
Adecco invests in IT as revenues dip in ‘challenging market’
Adecco comments
Alain Dehaze, Group Chief Executive Officer, said, “In Q3 2019, we delivered a solid performance in an uncertain external environment. We remain focused on our business transformation and continue to invest in our strategic priorities – GrowTogether, IT and our digital ventures – which are fundamentally strengthening our business. Our ongoing emphasis on value-based pricing and business mix improvement is driving a sustained increase in gross margin, which was up 60 basis points organically year-on-year. We also delivered strong performances in the Career Transition and Talent Development activities, with a return to growth in Lee Hecht Harrison and revenue acceleration in General Assembly, confirming the value that these businesses bring to our portfolio. As we look to the fourth quarter, we are continuing to build the next layer of the GrowTogether programme, with a focus on digital tools and solutions that deliver greater value to our clients and candidates. This includes rolling out an enhanced integrated front office solution, our global candidate app and the PERFORM methodology, putting us on track to deliver the EUR 250 million GrowTogether productivity target for 2020.”Investor notes
The Company’s shares have dipped 1.22% or 0.72p to 58.48p per share 05/11/19 12:44 CET. The Group’s market cap is 9.66 billion CHF, their dividend yield stands at 4.22%.First Derivatives shares spike as pre-tax profits rise
Trade war optimism runs out of puff
“The swell of trade optimism, enough to drive the Dow Jones to a fresh all-time high on Monday evening, failed to really carry over to Tuesday morning.”
“Instead the European markets yawned their way through the open, huffing the fumes of yesterday’s positivity to ensure that at the very least they kept their recent multi-week/month/year highs intact.”
“The FTSE, which is yet to recover all the losses incurred at the very start of October, added a handful of points, unable to cross 7400 but still at its best price in a month. The DAX was sitting pretty at 13130 without really moving, while the CAC was similarly unchanged at 5820, a level last seen 12 years prior.”
“Sterling, which on Monday showed its first election jitters – or, rather, the first since the vote was confirmed; in the run up to that announcement it was repeatedly anxious about the prospect – also failed to do much. Cable nudged up 0.1%, but remained shy of $1.29; against the euro, meanwhile, the pound was flat at €1.157.”
“If the currency is in the mood to look beyond politics, there’s the small matter of the latest UK services PMI. Analysts are expecting the mildest of improvements, from 49.5 to 49.6 month-on-month.”
Regarding Company news which has made markets nervous; Lloyds Banking Group (LON: LLOY) results disappointed and Deutsche Bank (ETR: DBK) reported losses during the third quarter.